. Author manuscript; available in PMC: 2014 Sep 1.

Published in final edited form as: Am Heart J. 2013 Aug 5;166(3):597–603. doi: 10.1016/j.ahj.2013.06.004

Table 4.

Percentage of patients achieving LDL-C Goals by Framingham risk stratification

Risk Category % (N)	Statin Discontinued Group n= 442	Intermittent Statin Dosing Group n= 149	Standard Statin Dosing Group n= 1014	Overall n=1605
Low 20 (325)	69 (88)^*^†	94 (24)	92 (214)	86 (325)
Moderate 38 (608)	44 (171)^*	44 (48)^*	81 (383)	68 (608)
Moderately high 15 (237)	45 (57)^*^†	82 (31)	90 (154)	79 (237)
High 27(435)	28 (126)^*	44 (46)	57 (263)	47 (435)
Total	44 (442)^*^†	61 (149)^*	79 (1014)	68 (1605)

p<0.05 compared with daily dosing;

^†

p<0.05 compared with intermittent dosing